Rafael Holdings Inc. RFL / USD Stock

Overview Charts & Stats for the Selected Time Period

This overview page provides a quick summary of the selected assets, including their latest prices, price changes, market capitalization changes, and more.

Settings

Asset RFL / USD

Latest Price 1.190

Price Change % Calculating...

Price Change X Calculating...

Up Days Calculating...

Down Days Calculating...

Avg Up Day % Calculating...

Avg Down Day % Calculating...

Median Up Day % Calculating...

Median Down Day % Calculating...

Volatility % 5.23%

Win Rate % 44.1%

CAGR % -51.31%

Best Day % +26.67%

Worst Day % -27.72%

Max Drawdown % -59.30%

Period High 2.85

Period Low 1.16

From High % -58.2%

From Low % +2.6%

Sharpe Ratio -0.01

Days >Avg % 41.7%

Total Volume 34,654,597

Volume: 2026-02-17

Aggregate Volume: 247 Days

Price Chart Percentage Gains

The price chart compares the percentage returns for each asset in the given time period. Each starts out at 0% at the x axis left most position.

Price Overlay ChartPercentage Gains

The overlay price chart displays the price movements of each asset over the selected period, using individual y-axes for each. This allows for an easy comparison of assets with different magnitudes, making it great for identifying correlations.

Volume Chart Daily Volume

This volume chart shows the daily volume for each asset.

Learn More

This page just gave you an overview, you might also want to check out the comprehensive stats, historical, correlation, volatility, and price projection pages.

What is Rafael Holdings Inc.?

Rafael Holdings Inc. is a holding company focused on acquiring and developing businesses in the healthcare sector. Its primary subsidiary, Rafael Pharmaceuticals, is dedicated to the development of novel cancer therapies. The company's pipeline includes potential treatments for various hematologic malignancies and solid tumors. The company operates within the biopharmaceutical industry, a segment characterized by extensive research and development, long product cycles, and significant regulatory hurdles. Rafael Pharmaceuticals leverages proprietary drug delivery technologies and a deep understanding of cancer biology to advance its drug candidates through clinical trials. Its therapeutic candidates target unmet medical needs, aiming to offer improved efficacy and reduced side effects compared to existing treatments. The market for oncology drugs is substantial and growing, driven by an aging global population and increased cancer incidence. Rafael Holdings Inc. aims to establish a strong market position by successfully bringing its innovative therapies to market and addressing critical patient needs.

🤖 AI Analysis

Model:

Ask me anything about the data on this page. I can help explain metrics, identify patterns, or answer specific questions.

Data sources

Trade hundreds of crypto perpetual futures